Healthcare & Life Sciences
ARMGO Pharma
Netherlandsarmgo.com
ARMGO Pharma is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About ARMGO Pharma
Based in the Netherlands, ARMGO Pharma is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ARMGO Pharma develops novel small molecule drugs called Rycals® that target ryanodine receptor calcium ion channels to treat diseases such as RyR1-related myopathies and catecholaminergic polymorphic ventricular tachycardia (CPVT).
Explore ARMGO Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.